Development of AL101 (GSK4527226), a progranulin-elevating monoclonal antibody, as a potential treatment for Alzheimer's disease. - Budda, Balasubrahmanyam; Mitra, Ananya; Park, Lovingly; Long, Hua; Kurnellas, Michael; Bien-Ly, Nga; Estacio, William; Burgess, Brady; Chao, Grace; Schwabe, Tina; Paul, Robert; Kenkare-Mitra, Sara; et al. (Alzheimer's Research & Therapy, 2025)